KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Other Working Capital Changes (2016 - 2025)

Novavax (NVAX) has 16 years of Other Working Capital Changes data on record, last reported at $559.5 million in Q4 2025.

  • For Q4 2025, Other Working Capital Changes rose 61384.99% year-over-year to $559.5 million; the TTM value through Dec 2025 reached -$61.0 million, up 82.76%, while the annual FY2025 figure was -$61.0 million, 82.76% up from the prior year.
  • Other Working Capital Changes reached $559.5 million in Q4 2025 per NVAX's latest filing, up from -$11.7 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $1.5 billion in Q4 2021 and bottomed at -$1.2 billion in Q3 2021.
  • Average Other Working Capital Changes over 5 years is $50.6 million, with a median of -$6.3 million recorded in 2024.
  • Peak YoY movement for Other Working Capital Changes: plummeted 6166.68% in 2021, then soared 61384.99% in 2025.
  • A 5-year view of Other Working Capital Changes shows it stood at $1.5 billion in 2021, then plummeted by 106.12% to -$93.9 million in 2022, then surged by 437.01% to $316.4 million in 2023, then crashed by 100.29% to -$913000.0 in 2024, then skyrocketed by 61384.99% to $559.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Working Capital Changes were $559.5 million in Q4 2025, -$11.7 million in Q3 2025, and -$535.0 million in Q2 2025.